SCHEMBL25818465

SCHEMBL25818465

Clc1nc(-c2cccc(-c3ccc4cccc(-c5cccc6ccccc56)c4c3)c2)nc(-c2ccc3oc4ccccc4c3c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
HSD17B10 Q99714 5/20 0.40
KDM4E B2RXH2 5/20 0.40
ATM Q13315 2/20 0.40
RAB9A P51151 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
AHR P35869 2/20 0.38
PLA2G2A P14555 3/20 0.38
PLA2G4A P47712 3/20 0.38
PLA2G10 O15496 1/20 0.38
MAPT P10636 5/20 0.38
HPGD P15428 5/20 0.38
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
PIM1 P11309 3/20 0.37
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818523 0.94 PLA2G2A (0.40) ALDH1A1HSD17B10KDM4EATMRAB9A
SCHEMBL25817789 0.90 PIM1 (0.41) ALDH1A1HSD17B10KDM4EATMRAB9A
SCHEMBL25818509 0.89 AHR (0.41) ALDH1A1HSD17B10KDM4ERAB9ACYP1A2
SCHEMBL25818478 0.89 PLA2G2A (0.36) ALDH1A1HSD17B10KDM4EATMRAB9A
SCHEMBL22161126 0.88 ALDH1A1 (0.39) ALDH1A1HSD17B10KDM4EATMRAB9A
SCHEMBL25818458 0.88 PLA2G2A (0.39) ALDH1A1HSD17B10KDM4EATMRAB9A
SCHEMBL25818443 0.88 AHR (0.38) ALDH1A1HSD17B10KDM4ERAB9AAHR
SCHEMBL25818546 0.88 AHR (0.40) ALDH1A1HSD17B10KDM4ERAB9ACYP1A2
SCHEMBL23437192 0.87 PLA2G2A (0.46) ALDH1A1KDM4ERAB9AAHRPLA2G2A
SCHEMBL29632998 0.87 PLA2G2A (0.46) ALDH1A1KDM4ERAB9AAHRPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885HSD17B10 3433/4885KDM4E 508/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885HSD17B10 3433/4885KDM4E 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.